These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 22197974)

  • 21. Detection of anti-protective antigen salivary IgG antibodies in recipients of the US licensed anthrax vaccine.
    Bienek DR; Chang CK; Cohen ME
    Vaccine; 2007 Aug; 25(32):5978-84. PubMed ID: 17597265
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anthrax Vaccine Precipitated Induces Edema Toxin-Neutralizing, Edema Factor-Specific Antibodies in Human Recipients.
    Dumas EK; Gross T; Larabee J; Pate L; Cuthbertson H; Charlton S; Hallis B; Engler RJM; Collins LC; Spooner CE; Chen H; Ballard J; James JA; Farris AD
    Clin Vaccine Immunol; 2017 Nov; 24(11):. PubMed ID: 28877928
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Qualification and performance characteristics of a quantitative enzyme-linked immunosorbent assay for human lgG antibodies to anthrax lethal factor antigen.
    Selinsky CL; Whitlow VD; Smith LR; Kaslow DC; Horton HM
    Biologicals; 2007 Apr; 35(2):123-9. PubMed ID: 17071101
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased long-term immunity to Bacillus anthracis protective antigen in mice immunized with a CIA06B-adjuvanted anthrax vaccine.
    Wui SR; Han JE; Kim YH; Rhie GE; Lee NG
    Arch Pharm Res; 2013 Apr; 36(4):464-71. PubMed ID: 23440578
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Poly-gamma-d-glutamic acid and protective antigen conjugate vaccines induce functional antibodies against the protective antigen and capsule of Bacillus anthracis in guinea-pigs and rabbits.
    Lee DY; Chun JH; Ha HJ; Park J; Kim BS; Oh HB; Rhie GE
    FEMS Immunol Med Microbiol; 2009 Nov; 57(2):165-72. PubMed ID: 19732139
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A plant based protective antigen [PA(dIV)] vaccine expressed in chloroplasts demonstrates protective immunity in mice against anthrax.
    Gorantala J; Grover S; Goel D; Rahi A; Jayadev Magani SK; Chandra S; Bhatnagar R
    Vaccine; 2011 Jun; 29(27):4521-33. PubMed ID: 21504775
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nasal immunization with a dual antigen anthrax vaccine induced strong mucosal and systemic immune responses against toxins and bacilli.
    Sloat BR; Cui Z
    Vaccine; 2006 Sep; 24(40-41):6405-13. PubMed ID: 16828937
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bridging non-human primate correlates of protection to reassess the Anthrax Vaccine Adsorbed booster schedule in humans.
    Schiffer JM; Chen L; Dalton S; Niemuth NA; Sabourin CL; Quinn CP
    Vaccine; 2015 Jul; 33(31):3709-16. PubMed ID: 26072016
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of a multiplexed fluorescent covalent microsphere immunoassay and an enzyme-linked immunosorbent assay for measurement of human immunoglobulin G antibodies to anthrax toxins.
    Biagini RE; Sammons DL; Smith JP; MacKenzie BA; Striley CA; Semenova V; Steward-Clark E; Stamey K; Freeman AE; Quinn CP; Snawder JE
    Clin Diagn Lab Immunol; 2004 Jan; 11(1):50-5. PubMed ID: 14715544
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacious, nontoxigenic Bacillus anthracis spore vaccines based on strains expressing mutant variants of lethal toxin components.
    Mendelson I; Gat O; Aloni-Grinstein R; Altboum Z; Inbar I; Kronman C; Bar-Haim E; Cohen S; Velan B; Shafferman A
    Vaccine; 2005 Dec; 23(48-49):5688-97. PubMed ID: 16039760
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A three-dose intramuscular injection schedule of anthrax vaccine adsorbed generates sustained humoral and cellular immune responses to protective antigen and provides long-term protection against inhalation anthrax in rhesus macaques.
    Quinn CP; Sabourin CL; Niemuth NA; Li H; Semenova VA; Rudge TL; Mayfield HJ; Schiffer J; Mittler RS; Ibegbu CC; Wrammert J; Ahmed R; Brys AM; Hunt RE; Levesque D; Estep JE; Barnewall RE; Robinson DM; Plikaytis BD; Marano N;
    Clin Vaccine Immunol; 2012 Nov; 19(11):1730-45. PubMed ID: 22933399
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potentiation of an anthrax DNA vaccine with electroporation.
    Luxembourg A; Hannaman D; Nolan E; Ellefsen B; Nakamura G; Chau L; Tellez O; Little S; Bernard R
    Vaccine; 2008 Sep; 26(40):5216-22. PubMed ID: 18462850
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasmid-based vaccination with candidate anthrax vaccine antigens induces durable type 1 and type 2 T-helper immune responses.
    Zhang Y; Qiu J; Zhou Y; Farhangfar F; Hester J; Lin AY; Decker WK
    Vaccine; 2008 Jan; 26(5):614-22. PubMed ID: 18166249
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rapid, sensitive, and specific lateral-flow immunochromatographic device to measure anti-anthrax protective antigen immunoglobulin g in serum and whole blood.
    Biagini RE; Sammons DL; Smith JP; MacKenzie BA; Striley CA; Snawder JE; Robertson SA; Quinn CP
    Clin Vaccine Immunol; 2006 May; 13(5):541-6. PubMed ID: 16682473
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantitative assessment of anthrax vaccine immunogenicity using the dried blood spot matrix.
    Schiffer JM; Maniatis P; Garza I; Steward-Clark E; Korman LT; Pittman PR; Mei JV; Quinn CP
    Biologicals; 2013 Mar; 41(2):98-103. PubMed ID: 23266055
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Selected research problems of anthrax vaccine development].
    Zakowska D; Kocik J; Bartoszcze M
    Przegl Epidemiol; 2009; 63(4):505-12. PubMed ID: 20120948
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immune responses to Bacillus anthracis protective antigen in patients with bioterrorism-related cutaneous or inhalation anthrax.
    Quinn CP; Dull PM; Semenova V; Li H; Crotty S; Taylor TH; Steward-Clark E; Stamey KL; Schmidt DS; Stinson KW; Freeman AE; Elie CM; Martin SK; Greene C; Aubert RD; Glidewell J; Perkins BA; Ahmed R; Stephens DS
    J Infect Dis; 2004 Oct; 190(7):1228-36. PubMed ID: 15346332
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of reduced dose schedules and intramuscular injection of anthrax vaccine adsorbed on immunological response and safety profile: a randomized trial.
    Wright JG; Plikaytis BD; Rose CE; Parker SD; Babcock J; Keitel W; El Sahly H; Poland GA; Jacobson RM; Keyserling HL; Semenova VA; Li H; Schiffer J; Dababneh H; Martin SK; Martin SW; Marano N; Messonnier NE; Quinn CP
    Vaccine; 2014 Feb; 32(8):1019-28. PubMed ID: 24373307
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular basis for improved anthrax vaccines.
    Brey RN
    Adv Drug Deliv Rev; 2005 Jun; 57(9):1266-92. PubMed ID: 15935874
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunogenicity and tolerance of ascending doses of a recombinant protective antigen (rPA102) anthrax vaccine: a randomized, double-blinded, controlled, multicenter trial.
    Gorse GJ; Keitel W; Keyserling H; Taylor DN; Lock M; Alves K; Kenner J; Deans L; Gurwith M
    Vaccine; 2006 Aug; 24(33-34):5950-9. PubMed ID: 16797805
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.